Search

everythinglearnresearchcommunity

for

Search:↓

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Watching, not removing, skin growths with moderate atypia and positive edges is okay; patients may get melanoma elsewhere, especially if they've had it before.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Lupus can cause hair loss and nail changes, with treatments available for both.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Pimecrolimus cream is not effective for treating alopecia areata.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

Most lupus patients in the study experienced hair loss, which greatly affected their mental and social well-being.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Clinical exams are good for diagnosing some women's hair loss, but lab tests aren't always needed.

Dermatologists can help diagnose endocrine disorders like PCOS and metabolic syndrome by looking at skin symptoms.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

The document concludes that mouse models are helpful but have limitations for skin wound healing research, and suggests using larger animals and genetically modified mice for better human application.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

A woman with dermatomyositis showed rare skin symptoms, was treated successfully, and her case suggests checking for cancer in similar patients.

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.

Lupus can look like hair loss from alopecia areata but needs different treatment.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.